Follow The Filings

WULF Terawulf Inc.

Financials, filed as TERAWULF INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 3 managers in 2026 Q2

  • 4 Owners
  • Max 3.7%
  • $917M
  • 3 add

In 2026 Q2 Stephen Mandel, Ben Hoskin, and Polen Capital Management added to Terawulf.

Who owns this now

Largest portfolio weights among holders, up to 3.7% (Stephen Mandel, Lone Pine Capital). Not free-float ownership.

  1. Stephen Mandel Add 3.7%
  2. Ben Hoskin Add 0.76%
  3. Senator Investment Group 0.13%
  4. Polen Capital Management Add 0.12%

Who owns WULF

Sorted by value, long equity only, as of 2026 Q2.

History
Stephen Mandel, Lone Pine Capital 3.7%, was 2.3% Add +21.2% 24,144,625 $596M History
Ben Hoskin, Value Aligned Research Advisors 0.76%, was 0.55% Add +56.3% 12,263,135 $303M History
Polen Capital Management 0.12%, was <0.01% Add +429.4% 563,139 $14M History
Senator Investment Group 0.13% Hold 139,071 $3.4M History

4 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by WULF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WULF insider trades
  • $440K bought by 1 insider
  • $17.2M sold by 4 insiders outside a trading plan
  • $18.9M sold by 1 insider under 10b5-1 plans
  1. Michael C. Bucella Director
    Buy
    $90K 6,085 shares at $14.79 +1.8% to stake
    Traded Sep 15 Filed Sep 16
    ↗
  2. Catherine J. Motz Director
    Sale
    $998K 56,023 shares at $17.81 27% of stake
    Traded Sep 8 Filed Sep 9
    ↗
  3. Walter E. Carter Director
    Sale
    $2M 130,626 shares at $15.14 36% of stake
    Traded Aug 31 Filed Sep 1
    ↗
  4. Paul B. Prager CEO
    Planned sale
    $2.3M 137,500 shares at $17.06 3.5% of stake
    Traded Aug 27 Filed Aug 28
    ↗
  5. Michael C. Bucella Director
    Buy
    $100K 5,883 shares at $16.99 +1.7% to stake
    Traded Aug 14–17 Filed Aug 17
    ↗
  6. Paul B. Prager CEO
    Planned sale
    $3.7M 137,500 shares at $26.60 3.4% of stake
    Traded Jun 29 Filed Jul 1
    ↗
  7. Paul B. Prager CEO
    Planned sale
    $8.4M 333,300 shares at $25.17 7.5% of stake
    Traded May 26–27 Filed May 28
    ↗
  8. Paul B. Prager CEO
    Sale
    $4.5M 216,700 shares at $20.73 20% of stake
    Traded Apr 27–28 Filed Apr 28
    ↗
  9. Paul B. Prager CEO
    Planned sale
    $4.5M 275,000 shares at $16.53 56% of stake
    Traded Mar 24–25 Filed Mar 25
    ↗
  10. Michael C. Bucella Director
    Buy
    $25K 1,665 shares at $15.04 +0.6% to stake
    Traded Mar 20 Filed Mar 20
    ↗
  11. Michael C. Bucella Director
    Buy
    $75K 4,835 shares at $15.57 +1.8% to stake
    Traded Mar 17–19 Filed Mar 19
    ↗
  12. Patrick Fleury CFO
    Sale
    $9.7M 600,000 shares at $16.14
    Traded Mar 17 Filed Mar 19
    ↗
  13. Michael C. Bucella Director
    Buy
    $20K 1,338 shares at $14.91 +0.5% to stake
    Traded Mar 11 Filed Mar 13
    ↗
  14. Michael C. Bucella Director
    Buy
    $30K 2,085 shares at $14.42 +0.8% to stake
    Traded Mar 5–9 Filed Mar 9
    ↗
  15. Michael C. Bucella Director
    Buy
    $50K 3,171 shares at $15.78 +1.2% to stake
    Traded Mar 4 Filed Mar 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 18 sales back to the company, 11 stock grants, 4 other transactions, 1 gift, and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 1.01,7.01,8.01,9.01 Filing Doc
8-K 1.01,2.03 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Gross profit $41.91M — $66.04M
Net income -$73.42M -$72.42M -$661.42M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.063B $0.281B $3.48B
Total non-current assets * $0.316B $0.506B $3.08B
Total assets $0.378B $0.788B $6.56B
Total current liabilities $0.155B $0.052B $1.74B
Total non-current liabilities * $0.001B $0.491B $4.68B
Total equity $222.49M $244.44M $140.44M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $4.26M -$24.42M -$123.18M
Cash from investing -$0.078B -$0.091B -$1.37B
Cash from financing $0.12B $0.335B $4.94B
Net change in cash $0.046B $0.22B $3.45B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf